Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA.
Panminerva Med. 2013 Jun;55(2):175-89.
The treatment of pulmonary sarcoidosis is based on several factors. These include changes in pulmonary physiology, presence of extra-pulmonary disease, and symptoms. Several immunosuppressive agents have been studied and recommendations regarding the utility of these different agents have evolved. While glucocorticoids remain the most commonly used agent, other drugs have been used as steroid sparing and for those patients who progress despite routine treatment. Non immunosuppressive agents also play a role in the therapy of pulmonary sarcoidosis patients. These include treatments for pulmonary hypertension, infection, and fatigue.
肺结节病的治疗基于多个因素。这些因素包括肺生理功能的变化、肺外疾病的存在以及症状。已经研究了几种免疫抑制剂，并且关于这些不同药物的使用的建议已经发展。虽然糖皮质激素仍然是最常用的药物，但其他药物已被用作类固醇节约剂，以及用于那些尽管常规治疗仍进展的患者。非免疫抑制剂在肺结节病患者的治疗中也发挥作用。这些包括治疗肺动脉高压、感染和疲劳。
